デフォルト表紙
市場調査レポート
商品コード
1610887

人工内耳:市場洞察・競合環境・市場予測 (~2030年)

Cochlear Implants - Market Insights, Competitive Landscape, and Market Forecast - 2030


出版日
発行
DelveInsight
ページ情報
英文 150 Pages
納期
2~10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
人工内耳:市場洞察・競合環境・市場予測 (~2030年)
出版日: 2024年12月01日
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

人工内耳の市場規模は、2023年の13億8,000万米ドルから、予測期間中はCAGR 9.92%で推移し、2030年には24億3,000万米ドルの規模に成長すると予測されています。

人工内耳の市場は、主に難聴の有病率の増加から大幅な市場成長を示しており、予測期間中も人工内耳への投資、人工内耳へのアクセス向上、支持的な償還政策などが市場の全体的な成長をさらに加速すると予測されています。

人工内耳:市場力学

世界保健機関 (WHO) のデータ (2024年) によると、2050年には約25億人が何らかの難聴を経験し、少なくとも7億人が世界中で聴覚リハビリテーションを必要とすると予測されています。さらに、同ソースによると、10億人以上の若年成人は、聞く習慣が安全でないため、永久的かつ予防可能な難聴の危険にさらされていると述べています。

WHOのデータ (2024年) によると、2021年にはアフリカで1億3,600万人が難聴を患い、2050年には3億3,700万人が聴覚の問題の影響を受けると予測されています。また、同ソースによると、欧州では2021年に1億9,600万人が難聴を患い、2050年には2億3,600万人が聴覚の問題の影響を受けると予測されています。

人工内耳は、重度の難聴に対処するために不可欠であり、個人に大きな利益をもたらします。聴覚神経を直接刺激することで、より良い音の知覚を可能にし、コミュニケーションと生活の質を向上させます。人工内耳は、未治療の難聴に関連する長期的なコストを削減するのに役立ちます。人工内耳は個人に力を与え、より活動的で自立した生活を可能にし、聴覚障害に関連する社会的・経済的コストを全体的に削減します。

好意的な償還政策と政府のイニシアチブにより、人工内耳へのアクセスは大幅に向上しています。世界のさまざまな国が似たような施策を実施しています。EUでは、多くの国が国の医療制度を通じて人工内耳に補助金を出したり、全額を負担したりしています

政府機関や非営利団体もまた、人工内耳をより利用しやすくするために大きく貢献しています。人工内耳財団 (Cochlear Implant Foundation) などの団体は、人工内耳を必要とする患者を支援するため、資金援助や政策変更を提唱しています。このようなイニシアチブは、聴覚技術の進歩をもっとも必要としている人々に確実に届け、難聴者の生活の質を向上させるために不可欠です。

これらのすべての要因が予測期間中の市場を牽引すると予想されています。

当レポートでは、世界の人工内耳の市場を調査し、市場概要、市場影響因子および市場機会の分析、法規制環境、市場規模の推移・予測、各種区分・地域/主要国別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 人工内耳市場レポート:イントロダクション

  • 調査範囲
  • 市場の分類
  • 市場の前提

第2章 人工内耳市場:エグゼクティブサマリー

  • 市場概要

第3章 競合情勢

第4章 規制分析

  • 米国
  • 欧州
  • 日本
  • 中国

第5章 人工内耳市場:主要要因分析

  • 市場促進要因
    • 難聴の増加
    • 有利な償還政策と政府の取り組み
    • 製品開発活動の活発化
  • 市場抑制要因と課題
    • めまいや眩暈などの手術後の問題
    • 聴性脳幹インプラントや骨伝導補聴器などの代替手段のアベイラビリティ
  • 市場機会
    • 小型化と美観の向上
    • 次世代サウンド処理の統合

第6章 人工内耳市場:ポーターのファイブフォース分析

第7章 人工内耳市場の評価

  • 埋め込み区分別
    • 片側
    • 両側
  • エンドユーザー別
    • 大人
    • 小児
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • その他の地域

第8章 人工内耳市場:企業と製品の概要

  • MED-EL Medical Electronics
  • Sonova.
  • Oticon Medical, LLC
  • Cochlear Ltd.
  • Envoy Medical.
  • TODOC Co., Ltd.
  • Advanced Bionics AG
  • ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD.
  • Shanghai Listent Medical TECH Co., Ltd.
  • Amplifon

第9章 KOLの見解

第10章 プロジェクトのアプローチ

第11章 DelveInsightについて

第12章 免責事項・問い合わせ

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Cochlear Implants Market in Global (2021-2030)
  • Table 3: Cochlear Implants Market in Global by Implantation (2021-2030)
  • Table 4: Cochlear Implants Market in Global by End-User (2021-2030)
  • Table 5: Cochlear Implants Market in Global by Geography (2021-2030)
  • Table 6: Cochlear Implants Market in North America (2021-2030)
  • Table 7: Cochlear Implants Market in the United States (2021-2030)
  • Table 8: Cochlear Implants Market in Canada (2021-2030)
  • Table 9: Cochlear Implants Market in Mexico (2021-2030)
  • Table 10: Cochlear Implants Market in Europe (2021-2030)
  • Table 11: Cochlear Implants Market in France (2021-2030)
  • Table 12: Cochlear Implants Market in Germany (2021-2030)
  • Table 13: Cochlear Implants Market in United Kingdom (2021-2030)
  • Table 14: Cochlear Implants Market in Italy (2021-2030)
  • Table 15: Cochlear Implants Market in Spain (2021-2030)
  • Table 16: Cochlear Implants Market in the Rest of Europe (2021-2030)
  • Table 17: Cochlear Implants Market in Asia-Pacific (2021-2030)
  • Table 18: Cochlear Implants Market in China (2021-2030)
  • Table 19: Cochlear Implants Market in Japan (2021-2030)
  • Table 20: Cochlear Implants Market in India (2021-2030)
  • Table 21: Cochlear Implants Market in Australia (2021-2030)
  • Table 22: Cochlear Implants Market in South Korea (2021-2030)
  • Table 23: Cochlear Implants Market in Rest of Asia-Pacific (2021-2030)
  • Table 24: Cochlear Implants Market in the Rest of the World (2021-2030)
  • Table 25: Cochlear Implants Market in the Middle East (2021-2030)
  • Table 26: Cochlear Implants Market in Africa (2021-2030)
  • Table 27: Cochlear Implants Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Cochlear Implants Market in Global (2021-2030)
  • Figure 3: Cochlear Implants Market in Global by Implantation (2021-2030)
  • Figure 4: Cochlear Implants Market in Global by End-User (2021-2030)
  • Figure 5: Cochlear Implants Market in Global by Geography (2021-2030)
  • Figure 6: Cochlear Implants Market in North America (2021-2030)
  • Figure 7: Cochlear Implants Market in the United States (2021-2030)
  • Figure 8: Cochlear Implants Market in Canada (2021-2030)
  • Figure 9: Cochlear Implants Market in Mexico (2021-2030)
  • Figure 10: Cochlear Implants Market in Europe (2021-2030)
  • Figure 11: Cochlear Implants Market in France (2021-2030)
  • Figure 12: Cochlear Implants Market in Germany (2021-2030)
  • Figure 13: Cochlear Implants Market in United Kingdom (2021-2030)
  • Figure 14: Cochlear Implants Market in Italy (2021-2030)
  • Figure 15: Cochlear Implants Market in Spain (2021-2030)
  • Figure 16: Cochlear Implants Market in the Rest of Europe (2021-2030)
  • Figure 17: Cochlear Implants Market in Asia-Pacific (2021-2030)
  • Figure 18: Cochlear Implants Market in China (2021-2030)
  • Figure 19: Cochlear Implants Market in Japan (2021-2030)
  • Figure 20: Cochlear Implants Market in India (2021-2030)
  • Figure 21: Cochlear Implants Market in Australia (2021-2030)
  • Figure 22: Cochlear Implants Market in South Korea (2021-2030)
  • Figure 23: Cochlear Implants Market in Rest of Asia-Pacific (2021-2030)
  • Figure 24: Cochlear Implants Market in the Rest of the World (2021-2030)
  • Figure 25: Cochlear Implants Market in the Middle East (2021-2030)
  • Figure 26: Cochlear Implants Market in Africa (2021-2030)
  • Figure 27: Cochlear Implants Market in South America (2021-2030)
  • Figure 28: Market Drivers
  • Figure 29: Market Barriers
  • Figure 30: Marker Opportunities
  • Figure 31: PORTER'S Five Force Analysis
目次
Product Code: DIMDCL0466

Cochlear implants Market by Implantation (Unilateral Implantation and Bilateral Implantation), End-User (Adults and Paediatrics), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a respectable CAGR forecast till 2030 owing to the increasing instances of hearing loss and rising product developmental activities across the world

The cochlear implants market was valued at USD 1.38 billion in 2023, growing at a CAGR of 9.92% during the forecast period from 2024 to 2030 to reach USD 2.43 billion by 2030. The cochlear implants market is observing substantial market growth primarily owing to the increasing prevalence of hearing loss & incurs substantial economic costs, investing in cochlear implants & improving access to these devices and supportive reimbursement policies are anticipated to further accelerate the overall growth of the cochlear implants market during the forecast period from 2024 to 2030.

Cochlear Implants Market Dynamics:

According to data from the World Health Organization (WHO) (2024), in 2050 about 2.5 billion are projected to experience some hearing loss, with at least 700 million individuals needing hearing rehabilitation globally. The above source further stated that more than 1 billion young adults are at risk of permanent and preventable hearing loss due to unsafe listening habits. To globally enhance ear and hearing care services, an additional annual investment of under USD 1.40 per person is required.

As per data from WHO (2024), in 2021, 136 million people were living with hearing loss in Africa, and by 2050, 337 million people would be affected by hearing problems in the African region. Additionally, according to the same source, in 2021, stated that 196 million people were affected by hearing loss in the European region. It also stated that by 2050, 236 million people would be affected by hearing problems in Europe.

Cochlear implants are essential in managing severe hearing loss, providing significant benefits for individuals. By directly stimulating the auditory nerve, these implants enable better sound perception, enhancing communication and quality of life. They help reduce the long-term costs associated with untreated hearing loss. Cochlear implants empower individuals, enabling them to lead more active and independent lives, thereby reducing the overall societal and economic costs associated with hearing impairment.

Favorable reimbursement policies and government initiatives are significantly enhancing access to cochlear implants. Globally, different countries have implemented similar measures. In the European Union, many nations provide subsidies or full coverage for cochlear implants through national health systems. For instance, the National Health Service in the UK covers cochlear implants for eligible patients, and similar programs exist across EU member states, aiming to improve accessibility.

Government and non-profit organizations also contribute significantly to making cochlear implants more accessible. Organizations such as the Cochlear Implant Foundation, provide funding assistance and advocate for policy changes to support individuals needing cochlear implants. These initiatives are vital in ensuring that advancements in hearing technology reach those who need them most, thereby improving the quality of life for individuals with hearing loss.

Therefore, the factors stated above collectively will drive the overall cochlear implant market growth.

However, post-surgical issues such as dizziness or vertigo and the availability of alternatives such as auditory brainstem implants and bone-anchored hearing systems, among others may prove to be challenging factors for the cochlear implant market growth.

Cochlear Implants Market Segment Analysis:

Cochlear implants market by Implantation (Unilateral Implantation and Bilateral Implantation), End-User (Adults and Paediatrics), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the implantation segment of the cochlear implants market, the bilateral implantation category is expected to have a significant revenue share in the year 2023. This can be ascribed to various key features and advantages offered by these. Key features include improved sound localization, which helps users identify the direction of sounds, enhancing safety and spatial awareness in daily life. Bilateral implants also improve speech perception, particularly in noisy environments, by providing a more balanced auditory input, allowing for better speech recognition. Additionally, bilateral implantation can help preserve auditory nerve function by stimulating both sides of the auditory pathway, which is crucial for maintaining the brain's auditory processing capabilities.

The advantages of bilateral cochlear implants are especially pronounced in children, as they support the development of more natural speech, language, and listening skills. Early bilateral implantation in children is associated with better academic outcomes and social integration due to enhanced communication abilities. In adults, bilateral implants can significantly improve the overall quality of life, as they provide a fuller, more immersive sound experience, reducing the impact of hearing loss on everyday interactions

Therefore the various features and advantages of bilateral implantation enhance performance and usability, solidifying the significant impact on the growth of the overall cochlear implants market during the forecast period from 2024 to 2030.

North America is expected to dominate the overall cochlear implants market:

Among all the regions, North America is expected to dominate the cochlear implants market in the year 2023 and is expected to do the same during the forecast period from 2024 to 2030. This can be attributed to several factors, including the increasing prevalence of hearing loss, ongoing advancements in cochlear implant technology, regulatory approvals for new and innovative devices, and the rising demand for effective hearing restoration solutions, which are acting as key factors contributing to the growth of the cochlear implants market in the North America region.

As per data from WHO (2024), in 2021, 217 million people were living with hearing loss in the US. The same source further stated that by 2050, 322 million people would be affected by hearing problems in the US.

Cochlear implants provide an effective solution for individuals with severe to profound hearing impairment, offering a pathway to improved communication and quality of life. By bypassing damaged parts of the inner ear and directly stimulating the auditory nerve, cochlear implants help restore hearing. As the prevalence of hearing problems continues to rise, cochlear implants serve as an essential intervention to mitigate the personal and societal impacts of hearing impairment.

Rising product developmental activities by regulatory bodies in the region will further boost the market for cochlear implants. For example, In January 2022, Cochlear Limited announced that it secured approval from the US Food and Drug Administration (FDA) for its Cochlear Nucleus Implants to treat unilateral hearing loss (UHL) and single-sided deafness (SSD).

In addition to this, in June 2022, Envoy Medical. received approval for its investigational device exemption (IDE) application from the US Food and Drug Administration (FDA), allowing the company to conduct an early feasibility study of the Acclaim cochlear implant. The company conducted a single-center study of the new fully implanted cochlear implant in the US.

Therefore, the interplay of all the aforementioned factors would provide a conducive growth environment for the North American cochlear implant market.

Cochlear Implants Market key players:

Some of the key market players operating in the cochlear implants market include MED-EL Medical Electronics., Sonova., Oticon Medical, LLC, Cochlear Ltd., Envoy Medical., TODOC Co., Ltd., Advanced Bionics AG, ZHEJIANG NUROTRON, BIOTECHNOLOGY CO., LTD., Shanghai Listent Medical TECH Co., Ltd., Amplifon, and others.

Recent Developmental Activities in the Cochlear Implants Market:

  • In November 2022, Cochlear Limited announced that the Cochlear Nucleus 8 Sound Processor received approval from the US Food and Drug Administration (FDA). The Nucleus 8 Sound Processor was described as the smallest and lightest behind-the-ear cochlear implant sound processor available in the industry.
  • In June 2021, Oticon received FDA pre-market approval (PMA) for its Neuro Cochlear implant system indicated to treat severe to profound sensorineural hearing loss.

Key Takeaways from the Cochlear Implants Market Report Study

  • Market size analysis for current cochlear implants market size (2023), and market forecast for 6 years (2024 to 2030)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the cochlear implants market.
  • Various opportunities available for the other competitors in the cochlear implants market space
  • What are the top-performing segments in 2023? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current cochlear implants market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for cochlear implant market growth in the coming future?

Target Audience who can be benefited from this Cochlear Implants Market Report Study

  • Cochlear implants product providers
  • Research organizations and consulting companies
  • Cochlear implants-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in cochlear implants
  • Various end-users who want to know more about the cochlear implants market and the latest technological developments in the cochlear implants market

Frequently Asked Questions for the Cochlear Implants Market:

1. What are Cochlear Implants?

Cochlear implant is a small electronic device that electrically stimulates the cochlear nerve. The implant has external and internal parts. The external part sits behind the ear and picks up sounds with a microphone. It then processes the sound and transmits it to the internal part of the implant.

2. What is the market for Cochlear Implants?

The cochlear implants market was valued at USD 1.38 billion in 2023, growing at a CAGR of 9.92% during the forecast period from 2024 to 2030 to reach USD 2.43 billion by 2030.

3. What are the drivers for the Cochlear Implants market?

The cochlear implants market is observing substantial market growth primarily owing to the increasing prevalence of hearing loss & incurs substantial economic costs, investing in cochlear implants & improving access to these devices and, supportive reimbursement policies are anticipated to further accelerate the overall growth of the cochlear implants market during the forecast period from 2024 to 2030.

4. Who are the key players operating in the Cochlear Implants market?

Some of the key market players operating in cochlear implants include MED-EL Medical Electronics., Sonova., Oticon Medical, LLC, Cochlear Ltd., Envoy Medical., TODOC Co., Ltd., Advanced Bionics AG, ZHEJIANG NUROTRON, BIOTECHNOLOGY CO., LTD., Shanghai Listent Medical TECH Co., Ltd., Amplifon, and others.

5. Which region has the highest share in the Cochlear Implants market?

North America is expected to dominate the overall Cochlear Implants market during the forecast period from 2024 to 2030. This can be attributed to several factors, including the increasing prevalence of hearing loss, ongoing advancements in cochlear implant technology, regulatory approvals for new and innovative devices, and the rising demand for effective hearing restoration solutions, which are acting as key factors contributing to the growth of the cochlear implants market in the North America region.

Table of Contents

1. Cochlear Implants Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Cochlear Implants Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Cochlear Implants Market Key Factors Analysis

  • 5.1. Cochlear Implants Market Drivers
    • 5.1.1. Increasing instances of hearing loss
    • 5.1.2. Favorable reimbursement policies and government initiatives
    • 5.1.3. Rising product developmental activities
  • 5.2. Cochlear Implants Market Restraints and Challenges
    • 5.2.1. Post-surgical issues such as dizziness or vertigo
    • 5.2.2. Availability of alternatives such as auditory brainstem implants and bone-anchored hearing systems
  • 5.3. Cochlear Implants Market Opportunities
    • 5.3.1. Miniaturization and improved aesthetics
    • 5.3.2. Integration of next-generation sound processing

6. Cochlear Implants Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Cochlear Implants Market Assessment

  • 7.1. By Implantation
    • 7.1.1. Unilateral Implantation
    • 7.1.2. Bilateral Implantation
  • 7.2. By End-User
    • 7.2.1. Adults
    • 7.2.2. Paediatrics
  • 7.3. By Geography
    • 7.3.1. North America
      • 7.3.1.1. United States Cochlear Implants Market Size in USD million (2021-2030)
      • 7.3.1.2. Canada Cochlear Implants Market Size in USD million (2021-2030)
      • 7.3.1.3. Mexico Cochlear Implants Market Size in USD million (2021-2030)
    • 7.3.2. Europe
      • 7.3.2.1. France Cochlear Implants Market Size in USD million (2021-2030)
      • 7.3.2.2. Germany Cochlear Implants Market Size in USD million (2021-2030)
      • 7.3.2.3. United Kingdom Cochlear Implants Market Size in USD million (2021-2030)
      • 7.3.2.4. Italy Cochlear Implants Market Size in USD million (2021-2030)
      • 7.3.2.5. Spain Cochlear Implants Market Size in USD million (2021-2030)
      • 7.3.2.6. Rest of Europe Cochlear Implants Market Size in USD million (2021-2030)
    • 7.3.3. Asia-Pacific
      • 7.3.3.1. China Cochlear Implants Market Size in USD million (2021-2030)
      • 7.3.3.2. Japan Cochlear Implants Market Size in USD million (2021-2030)
      • 7.3.3.3. India Cochlear Implants Market Size in USD million (2021-2030)
      • 7.3.3.4. Australia Cochlear Implants Market Size in USD million (2021-2030)
      • 7.3.3.5. South Korea Cochlear Implants Market Size in USD million (2021-2030)
      • 7.3.3.6. Rest of Asia-Pacific Cochlear Implants Market Size in USD million (2021-2030)
    • 7.3.4. Rest of the World (RoW)
      • 7.3.4.1. Middle East Cochlear Implants Market Size in USD million (2021-2030)
      • 7.3.4.2. Africa Cochlear Implants Market Size in USD million (2021-2030)
      • 7.3.4.3. South America Cochlear Implants Market Size in USD million (2021-2030)

8. Cochlear Implants Market Company and Product Profiles

  • 8.1. MED-EL Medical Electronics.
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Sonova.
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Oticon Medical, LLC
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. Cochlear Ltd.
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Envoy Medical.
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. TODOC Co., Ltd.
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. Advanced Bionics AG
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD.
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Shanghai Listent Medical TECH Co., Ltd.
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. Amplifon
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us